Endometrial cancer differential diagnosis: Difference between revisions

	Endometrial cancer Microchapters
Home
Patient Information
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Endometrial cancer from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Endometrial cancer differential diagnosis On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Endometrial cancer differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Endometrial cancer differential diagnosis
CDC on Endometrial cancer differential diagnosis
Endometrial cancer differential diagnosis in the news
Blogs on Endometrial cancer differential diagnosis
Directions to Hospitals Treating Endometrial cancer
Risk calculators and risk factors for Endometrial cancer differential diagnosis

VisualWikitext

Revision as of 19:15, 29 January 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]Roukoz A. Karam, M.D.[3]

Overview

In early stages endometrial cancer must be differentiated from diseases that cause abnormal uterine bleeding and endometrial thickening on ultrasound, such as endometrial hyperplasia, endometrial polyp and submucosal uterine leiomyoma. In advanced stages endometrial cancer must be differentiated from uterine sarcoma and uterine lymphoma.

Differentiating Endometrial Cancer From Other Diseases

In early disease, uterine cancer must be differentiated from other diseases causing endometrial thickening:^[1]

Benign endometrial proliferation
Endometrial hyperplasia
Endometrial polyp
Submucosal uterine leiomyoma

In advanced disease, uterine cancer must be differentiated from other diseases:^[1]

Uterine sarcoma

Endometrial stromal sarcoma (ESS)
Leiomyosarcoma of the uterus
Malignant mixed Mullerian tumour (MMMT) of the uterus

Uterine lymphoma: rare

Primary uterine lymphoma
Secondary uterine involvement with lymphoma

Cervical cancer with uterine invasion
Metastasis to the uterus from a non gynecological malignancy: rare

	Symptoms				Physical examination		Lab Findings		Imaging
Diseases	Clinical manifestations						Para-clinical findings				Pap Smear	Histopathology	Gold standard	Additional findings
	Symptoms				Physical examination		Para-clinical findings
	Vaginal Bleeding	Pelvic Pain	Pelvic Pressure	Abdominal Distention	Pelvic Mass	Abdominal Distension	Hb	CEA-19	Ultrasound	MRI
Uterine cancer
Uterine sarcoma
Uterine lymphoma
Uterine leiomyoma
Malignant mixedMullerian tumour (MMMT) of the uterus
Cervical cancerwith uterine invasion
Metastasis to the uterusfrom a non gynaecologcial malignancy
Endometrial polyp
Endometrial hyperplasia
Fetus
Uterine adenomyoma
Hematometra

References

↑ ^1.0 ^1.1 Hippisley-Cox J, Coupland C (2011). "Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm". BMJ. 344: d8009. doi:10.1136/bmj.d8009. PMC 3251328. PMID 22217630.

Template:WikiDoc Sources

[pmid22217630-1] 1.0 ^1.1 Hippisley-Cox J, Coupland C (2011). "Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm". BMJ. 344: d8009. doi:10.1136/bmj.d8009. PMC 3251328. PMID 22217630.

[1]

@@ Line 28: / Line 28: @@
 | colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''<small>Clinical manifestations</small>'''
 ! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |<small>Para-clinical findings</small>
-! rowspan="2" |
+| rowspan="4" |<small>'''Pap Smear'''</small>
+! rowspan="4" |<small>Histopathology</small>
 | colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''<small>Gold standard</small>'''
 ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |<small>Additional findings</small>
@@ Line 37: / Line 38: @@
 ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |<small>Lab Findings</small>
 ! colspan="2" |<small>Imaging</small>
-! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |<small>Histopathology</small>
-! rowspan="2" |<small>Pap Smear</small>
 |-
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |<small>Vaginal B</small><small>leeding</small>
@@ Line 62: / Line 61: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Uterine sarcoma|<small>Uterine</small>]]
@@ Line 79: / Line 78: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphoma|<small>Uterine</small>]]
@@ Line 96: / Line 95: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |<small>Uterine</small> <small>[[leiomyoma]]</small>
@@ Line 112: / Line 111: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |<small>Malignant</small> <small>mixed</small><small>Mullerian</small>
@@ Line 134: / Line 133: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |<small>[[Cervical cancer|Cervical]]</small> <small>[[Cervical cancer|cancer]]</small><small>with</small>
@@ Line 154: / Line 153: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |<small>[[Metastasis]]</small> <small>to the uterus</small><small>from a non gynaecologcial</small>
@@ Line 172: / Line 171: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Endometrial polyp|<small>Endometrial</small>]]
@@ Line 189: / Line 188: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Endometrial hyperplasia|<small>Endometrial</small>]]
@@ Line 206: / Line 205: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |<small>[[Fetus]]</small>
@@ Line 222: / Line 221: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Adenomyoma|<small>Uterine</small>]]
@@ Line 239: / Line 238: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hematometra|<small>Hematometra</small>]]
@@ Line 255: / Line 254: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 |-
 |

Endometrial cancer differential diagnosis: Difference between revisions

Revision as of 19:15, 29 January 2019

Overview

Differentiating Endometrial Cancer From Other Diseases

References

Navigation menu